ONCOLife as a cutting-edge oncology magazine designed for oncologists and health professionals. It has flexible format, available both in print and online formats in the US and EU, ONCOLife is ...
Oncolytic viruses are emerging as a promising development in cancer treatment, not only destroying cancer cells but also modulating the tumor microenvironment to enhance immune responses. We had an ...
Ariceum Therapeutics announced that the US FDA has cleared its investigational new drug (IND) application to commence a Phase I/II clinical trial of its proprietary radiolabelled peptide, 225Ac-SSO110 ...
The START Center for Cancer Research dosed the first U.S. patient in Moderna’s Phase 1 trial of mRNA-4106, a multivalent mRNA-based cancer vaccine targeting advanced solid tumors. The study evaluates ...
Vergent Bioscience has launched the Phase 3 VISUALIZE 2 trial evaluating abenacianine, a tumor-activated imaging agent designed to enhance intraoperative tumor detection in lung cancer surgery. The ...
We are pleased to present an exclusive interview with Dana Brown, CEO and Chairman of the Board at iCAD Inc., to explore the future of breast cancer screening and the role of artificial intelligence ...
Engineered Oncolytic Virus Reprograms Immunity and Extends Survival in Brain Cancer ...
Oregon Therapeutics & Lantern Pharma launch a strategic AI collaboration to optimize XCE853, a novel cancer drug candidate. Demonstrating efficacy in solid and hematological cancers, XCE853 is poised ...
Novartis announced plans to build a fourth US radioligand therapy manufacturing facility in Winter Park, Florida, as part of its $23 billion US investment. The 35,000-square-foot, purpose-built site ...
Health and Pharma is a pioneering news and communications platform focused on health science, biotechnology, and pharmaceutical developments.
The U.S. Food and Drug Administration (FDA) recently published a report highlighting the benefits and risks of emerging augmented and virtual reality (AR/VR) medical devices. While these tools offer ...
The FDA has approved the Altius® System, an innovative device for managing chronic pain in lower limb amputees. Utilizing direct electrical nerve stimulation, the device proved effective in reducing ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results